Royal Bank of Canada
IMMX icon

Royal Bank of Canada’s Immix Biopharma IMMX Stock Holding History

Royal Bank of Canada’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Sell
59
-936
-94% -$6.87K ﹤0.01% 6877
2025
Q4 		$5K Buy
+995
New +$4.09K ﹤0.01% 6712
2025
Q3 		– Sell
-11,168
Closed -$23K – 7300
2025
Q2 		$23K Buy
+11,168
New +$22.5K ﹤0.01% 6211
2025
Q1 		– Sell
-2,000
Closed -$4K – 7013
2024
Q4 		$4K Sell
2,000
-82,000
-98% -$150K ﹤0.01% 6581
2024
Q3 		$125K Buy
84,000
+83,867
+63,058% +$169K ﹤0.01% 5183
2024
Q2 		$0 Buy
133
+127
+2,117% +$292 ﹤0.01% 7271
2024
Q1 		$0 Sell
6
-62
-91% -$240 ﹤0.01% 7263
2023
Q4 		$0 Buy
+68
New +$308 ﹤0.01% 7325

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Royal Bank of Canada's IMMX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Immix Biopharma (IMMX) stake by 94% in Q1 2026, selling an estimated $6.87K and leaving 59 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6877.

Royal Bank of Canada first reported a position in IMMX in Q4 2023 and has held it in 8 quarters since. The position peaked at $125K in Q3 2024. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Royal Bank of Canada held 59 shares of Immix Biopharma worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 936 Immix Biopharma shares in Q1 2026, an estimated $6.87K.
  • Immix Biopharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6877 holding.
  • Royal Bank of Canada first reported a position in Immix Biopharma in Q4 2023 and has held it in 8 quarters since.
  • Royal Bank of Canada's Immix Biopharma position peaked at $125K in Q3 2024.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.